Sweden· SE-20120809000026
Zevtera 500 mg Pulver till koncentrat till infusionsvätska, lösning
A medicinal product containing ceftobiprole medocaril sodium, registered in Sweden by Basilea Pharmaceutica Deutschland GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ceftobiprole Medocaril Sodium
- Manufacturer
- Basilea Pharmaceutica Deutschland GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120809000026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftobiprole medocaril sodium in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMabelio 500 mgBasilea Medical
- FinlandZevteraBasilea Pharmaceutica Deutschland GmbH
- IrelandAdaluzis 500mg Powder for concentrate for solution for infusionAdvanz Pharma Limited
- NorwayZevteraBasilea Pharmaceutica Deutschland GmbH
- United StatesZEVTERALa Jolla Pharmaceutical Company
- GermanyZevteraAdvanz Pharma Limited
- FranceMABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusionADVANZ PHARMA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Zevtera
- Germany · Zevtera
- Denmark · Zevtera
- Spain · Zevtera
- Finland · Zevtera
- France · Mabelio
- United Kingdom (Northern Ireland) · Zevtera
- Ireland · Adaluzis
- Italy · Mabelio
- Luxembourg · Mabelio, Zevtera
- Norway · Zevtera
- Poland · Zevtera
- Portugal · Zevtera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/632058ec-887a-4bbc-95c9-e3bb186a387b GET /v1/drugs/632058ec-887a-4bbc-95c9-e3bb186a387b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20120809000026",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120809000026",
"product_doc_link": "https://docetp.mpa.se/LMF/Zevtera%20powder%20for%20concentrate%20for%20solution%20for%20infusion%20ENG%20SmPC_09001bee807a8688.pdf"
}See everything about ceftobiprole medocaril sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.